elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
LNCaP
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
LNCaP
RIS
0.001
(Research Intensity Score)
Papers
156
Top papers
Enhancing the anticancer effects of rosmarinic acid in PC3 and LNCaP prostate cancer cells using titanium oxide and selenium-doped graphene oxide nanoparticles
2025 · 15 citations
Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound
2022 · 54 citations
Utilizing two-dimensional monolayer and three-dimensional spheroids to enhance radiotherapeutic potential by combining gold nanoparticles and docetaxel
2023 · 25 citations
Green-Synthesized Silver Nanoparticles Coated with Alginate and Conjugated to Docetaxel Drug: Combination Therapy Under X-Irradiation on LNCaP Prostate Cancer Cells
2025 · 7 citations
Improved Anticancer Properties of Silver Nanoparticles by Albumin Coating in Prostate Cancer Cell Lines: An In Vitro Study
2026 · 2 citations
Sugar Amino Acid Linkers for the Design of [ 18 F]SiFA‐PSMA Radioligands
2026
Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
2022 · 48 citations
Combination of the extract from Phellinus linteus with Smilax spp. attenuates colorectal and prostate cancers
2026
Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells
2026
Newest papers
Improved Anticancer Properties of Silver Nanoparticles by Albumin Coating in Prostate Cancer Cell Lines: An In Vitro Study
2026 · 2 citations
Sugar Amino Acid Linkers for the Design of [ 18 F]SiFA‐PSMA Radioligands
2026
Combination of the extract from Phellinus linteus with Smilax spp. attenuates colorectal and prostate cancers
2026
Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells
2026
Nanoparticle-enhanced apigenin suppresses androgen receptor signaling and cellular plasticity in LNCaP cells
2026
Automated radiosynthesis and biodistribution of [18F]fluoroflutamide
2026
Synthesis, radiolabeling, and biodistribution evaluation of novel hyperbranched polyglycerols-based radiotracers for targeting PSMA in prostate cancer
2026
Engineered prostate-specific membrane antigen-targeted liposomal nanoplatform integrating near-infrared fluorescence, ultrasound, and magnetic resonance imaging for precision prostate cancer imaging
2026 · 1 citations
Surface-Modified Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a New Perspective for Prostate Cancer Therapy
2026 · 2 citations
Browse all papers →
LNCaP's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
LNCaP's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link